Explore
Validate
LearnABIN2846978
antibody from antibodies-online
Targeting: RBM39
CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2846978 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-RNA Binding Motif Protein 39 (RBM39) (AA 114-143), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 114-143, N-Term
- Antibody clone number
- RB34152
- Vial size
- 80 μL
- Storage
- RBM39 Antibody (N-term) can be refrigerated at 2-8°C for up to 6 months. For long term storage, place the at -20°C.
Submitted references Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.
CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.
Mercier I, Casimiro MC, Zhou J, Wang C, Plymire C, Bryant KG, Daumer KM, Sotgia F, Bonuccelli G, Witkiewicz AK, Lin J, Tran TH, Milliman J, Frank PG, Jasmin JF, Rui H, Pestell RG, Lisanti MP
The American journal of pathology 2009 Apr;174(4):1172-90
The American journal of pathology 2009 Apr;174(4):1172-90
CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.
Dutta J, Fan G, Gélinas C
Journal of virology 2008 Nov;82(21):10792-802
Journal of virology 2008 Nov;82(21):10792-802
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
